Indication
Stargardt Macular Dystrophy
3 clinical trials
3 products
Clinical trial
An Open Label Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular DegenerationStatus: Active (not recruiting), Estimated PCD: 2033-08-29
Product
SAR422459Product
ALK-001Clinical trial
A Phase 2 Multicenter, Double-Masked, Randomized, Placebo-Controlled Study to Investigate the Long Term Safety, Tolerability, Pharmacokinetics and Effects of ALK-001 on the Progression of Stargardt DiseaseStatus: Recruiting, Estimated PCD: 2024-12-01
Product
PlaceboClinical trial
A Phase 2 Multicenter, Double-Masked, Randomized, Placebo-Controlled Study to Investigate the Long Term Safety, Tolerability, Pharmacokinetics and Effects of ALK-001 on the Progression of Stargardt DiseaseStatus: Recruiting, Estimated PCD: 2024-12-01